New Treatment Strategy for Down Syndrome Shows Promise in Phase 2 Clinical Trial
Rapid Read

New Treatment Strategy for Down Syndrome Shows Promise in Phase 2 Clinical Trial

What's Happening? Researchers at the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz have reported promising results from a Phase 2 clinical trial for a new treatment strategy for Down syndrome. The study, published in Cell Reports Medicine, investigated the use of tof
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.